MedTrace Logo

Low-dose UVA1 Radiation in Cutaneous Lupus Patients

NCT01776190 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2023-08-25

Study results available
· View outcomes & findings →

Summary

The investigators are conducting an open-label clinical trial determining the effects of UVA1 phototherapy on cutaneous lupus (CLE) patients. Past research on systemic lupus (SLE) subjects indicates that this treatment is likely to be effective in treating cutaneous lupus with few side effects. The fact that most CLE patients are seen at dermatology clinics also increases the usefulness of this study because there is a large probability that phototherapy treatment will be accessible for many of the patients that stand to benefit from it.

Conditions

  • Cutaneous Lupus Erythematosus

Interventions

DEVICE

UVA1 radiation treatment

Sponsors & Collaborators

  • Daavlin Corporation

    collaborator INDUSTRY

  • Ben Chong

    lead OTHER

Principal Investigators

  • Benjamin F Chong, MD, MSCS · University of Texas Southwestern Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01776190 on ClinicalTrials.gov